F
Fergus Shanahan
Researcher at National University of Ireland
Publications - 727
Citations - 59181
Fergus Shanahan is an academic researcher from National University of Ireland. The author has contributed to research in topics: Inflammatory bowel disease & Gut flora. The author has an hindex of 117, co-authored 705 publications receiving 51963 citations. Previous affiliations of Fergus Shanahan include Imperial College London & Mater Misericordiae Hospital.
Papers
More filters
Journal ArticleDOI
The effect of immunosuppression on patch testing: A cross-sectional study in patients with inflammatory bowel disease.
Journal ArticleDOI
Su2001 Altered Expression and Activation of the CXCR3/CXCL10 Chemokine System in Irritable Bowel Syndrome (IBS) Mucosal Biopsy Tissue
Gerard M. Moloney,Aine Fanning,John Mac Sharry,Lindsay J. Hall,Fergus Shanahan,Eamonn Martin Quigley,Silvia Melgar,Kenneth Nally +7 more
TL;DR: Reduced small bowel transit 12h following TNBS suggests rapid functional changes in response to the inflammatory insult, and supports the concept that PVG neurons contribute to small bowel motor dysfunction during colitis.
Journal ArticleDOI
Celiac disease and Addison's disease — a clinical pitfall
C. O'Leary,Howel C. Walsh,Peter Wieneke,Paud O'Regan,Eamonn Martin Quigley,Fergus Shanahan,Cornelius C. Cronin +6 more
Journal ArticleDOI
The pancreas, primary biliary cirrhosis and the dry gland syndrome
TL;DR: Pancreatic exocrine function was studied in patients with primary biliary cirrhosis and an equal number of normal controls and revealed no significant differences.
Journal ArticleDOI
Bone marrow micrometastases in oesophago-gastric cancer — Evidence for clearance in patients receiving neoadjuvant chemoradiotherapy
Paul Ryan,Sean McCarthy,J Kelly,M. S. Grannell,John Kevin Collins,L. Grogan,O. Breathnach,Fergus Shanahan,T. N. Walsh,Gerald C. O'Sullivan +9 more
TL;DR: In patients with oesophagogastric malignancy the incidence of bone marrow micrometastases is reduced by neoadjuvant chemo-radiotherapy, however, micromETastatic cells are still present in a significant proportion of treated patients suggesting resistance of the tumour cell to the chemotherapeutic agents.